Cancer That Can “Wait 40 Years”: The Hidden Mesothelioma Epidemic in the United States

Researchers from the Sylvester Comprehensive Cancer Center have conducted a large-scale analysis of mesothelioma trends in the United States. The study, published in JCO Global Oncology, highlights the continuing public health burden of this rare but highly aggressive cancer, which is closely linked to asbestos exposure.

Mesothelioma develops primarily after prolonged contact with asbestos, a material that was once widely used in shipbuilding, construction, and industrial manufacturing. Although asbestos use has declined significantly in recent decades, the disease remains a major health concern due to its exceptionally long latency period, which can extend for 20 to 40 years or more after exposure.

The researchers analyzed data from all 50 U.S. states between 1990 and 2023, examining disease incidence, mortality, and disability-related health burdens.

While age-standardized rates of mesothelioma incidence and mortality declined by roughly one-third over the study period, the absolute number of cases increased by nearly 30%. The total number of deaths also rose, and the overall burden of disease increased by approximately 14%.

According to the authors, declining relative rates do not necessarily indicate a reduced public health impact. Instead, population growth and aging have contributed to a larger number of affected individuals.

The study also revealed significant differences between men and women. Among men, both incidence and mortality rates declined substantially, reflecting the gradual disappearance of generations that worked in industries with high occupational asbestos exposure.

In contrast, women experienced little or no decline in disease rates, and some states even reported increases. The researchers suggest that women are more likely to be exposed through non-occupational routes, including household contact with asbestos-contaminated clothing, environmental exposure, and aging buildings, schools, and infrastructure containing asbestos materials.

Geographic analysis showed that the highest disease burden remains concentrated in states with historical industrial activity, particularly those associated with shipbuilding, mining, and widespread asbestos use in construction.

Another major finding was the persistently high fatality rate of mesothelioma. The ratio of deaths to diagnosed cases remains close to one, indicating that most patients ultimately die from the disease. Despite advances in treatment, including immunotherapy, survival outcomes have improved only modestly over recent decades.

The researchers estimate that approximately 96% of mesothelioma-related deaths are still attributable to occupational asbestos exposure, making the disease one of the most preventable forms of cancer.

The authors conclude that reducing the future burden of mesothelioma will require two key strategies: more aggressive removal and management of remaining asbestos in buildings and infrastructure, and the development of more effective treatments for patients who develop the disease.

The findings serve as a reminder that the health consequences of past asbestos use continue to emerge decades after exposure, creating a long-lasting legacy that remains visible in public health statistics today.

Follow NEWS.am Medicine on Facebook and Twitter